Clonazepam
Klonopin
Benzodiazepine
NADAC/unit
$0.0206
Active Shortage
Tier 1: 226.1%
PA Req: 17.0%
11 Manufacturers
39 ANDAs
Clonazepam treats anxiety, seizures, and insomnia by enhancing GABA activity in the brain.
vs. brand Klonopin: Generic saves up to 100% per unit
Active Shortages
2023-03-27 Marketed by Advagen Pharma Ltd., Rubicon Research Private Limited
2023-03-10 Shortage reported, Aurobindo Pharma USA
2023-03-10 Marketed by Advagen Pharma Ltd., Rubicon Research Private Limited
2023-03-10 Shortage reported, Aurobindo Pharma USA
2023-03-10 Shortage reported, Accord Healthcare Inc.
Market Intelligence
2025-01-15 Class I Recall: Endo USA, Inc.
2025-01-15 Class I Recall: Endo USA, Inc.
2025-01-15 Class I Recall: Endo USA, Inc.
2025-01-15 Class I Recall: Endo USA, Inc.
2024-08-07 Class I Recall: Endo Pharmaceuticals, Inc.
Generic Manufacturers
ACCORD HEALTHCARE INCACTAVIS ELIZABETH LLCALEMBIC PHARMACEUTICALS LTDAUROBINDO PHARMA USA INCBARR LABORATORIES INCCHARTWELL RX SCIENCES LLCCHEPLAPHARM ARZNEIMITTEL GMBHPH HEALTH LTDPRINSTON PHARMACEUTICAL INCRUBICON RESEARCH LTDSANDOZ INCTEVA PHARMACEUTICALS USA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.